Sanofi

Sanofi (ticker SNY) is a large, France‑headquartered pharmaceutical company with a market capitalisation of about $122.84 billion. It develops, manufactures and markets prescription medicines, vaccines and specialty products across multiple therapeutic areas such as diabetes, rare diseases, immunology and oncology. Sanofi combines established, revenue‑generating medicines with an active research and development pipeline; revenues come from product sales, vaccines (Sanofi Pasteur), licensing and collaborations. Investors typically watch pipeline milestones, regulatory approvals, pricing and reimbursement dynamics, and the impact of patent expiries — all of which materially affect revenues and valuation. The company’s global scale helps diversify geographic exposure, but product concentration, clinical setbacks and regulatory or pricing pressures present risks. Shares may suit investors seeking large‑cap pharmaceutical exposure who are comfortable with clinical and commercial uncertainty. This is general educational information, not personal financial advice; values can rise and fall and returns are not guaranteed. Consider your own situation or consult a professional for suitability.